XML 13 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Net income (loss) $ 794,010 $ (937,483)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 41,125 37,846
Amortization of right of use assets 99,663 0
Provision for inventory obsolescence 27,000 45,000
Change in fair value of common stock warrant 73,000 0
Non-cash stock-based compensation 11,117 13,177
Changes in assets and liabilities:    
Decrease in accounts receivable 894,205 325,496
(Increase) decrease in inventories (168,116) 462,770
(Increase) decrease in prepaid expenses & other assets (20,587) 16,911
Decrease in accounts payable and other accrued expenses (401,565) (225,114)
Increase (decrease) in accrued payroll, vacation pay and payroll taxes 71,921 (84,275)
Increase in deferred revenues 306,405 242,963
Decrease in operating lease liabilities (99,663) 0
Increase in accrued legal damages 171,106 84,654
Net cash provided by (used in) operating activities 1,799,621 (18,055)
Cash flows from investing activities:    
Purchases of equipment (63,536) 0
Net cash used in investing activities (63,536) 0
Cash flows from financing activities:    
Repayment of long-term debt 0 (2,124)
Repayment of line of credit (70,000) (160,000)
Proceeds from short-swing profits from an investor 0 156,175
Repayment of finance lease obligations (3,683) (3,358)
Net cash used in financing activities (73,683) (9,307)
Net increase (decrease) in cash, cash equivalents and restricted cash 1,662,402 (27,362)
2,590,727 2,308,678
Taxes paid 0 0
Interest paid 28,165 28,278
4,253,129 2,281,316
Cash and cash equivalents 585,856 307,812
Restricted cash 2,004,871 2,000,866
Cash and cash equivalents 2,246,595 278,443
Restricted cash $ 2,006,534 $ 2,002,873